OpenVSafe by OpenVAERS
Search V-safe

ET4-16549-64275

1 vaccination 1 coded response 5 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
950 / CA
Registered
2021-01-30
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-30
    Registered in v-safe
  3. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  4. 2021-01-30
  5. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Axillary pain — Feeling: Good
    Free text: Sore armpits
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-07-30
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  8. 2022-01-31
    Health check-in — 12 months, dose 1
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-29Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-01

Systemic reaction (other): Sore armpits

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAxillary pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release